The results proved that SNHG17 induced by YY1 facilitated the glioma progression through targeting miR-506-3p/CTNNB1 axis by activation of Wnt/β-catenin signaling pathway, suggesting its potential value as a biomarker in glioma. Here, CTNNB1 is linked to glioma.